Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

  • Post category:News / Research

TLN_April2022_p342_354 (pdf)

The Lancet Neurology April2022 p342_354 (online)

from The Lancet Neurology